X4 Therapeutics, Inc.

SEC CIK 0001632304

CIK #1632304

The following is an index of Security and Exchange Commission registration information for X4 Therapeutics, Inc.. This page includes all SEC filing details as well as a list of any documents registered by X4 Therapeutics, Inc..
Latest Edgar Filing Status
Updated2019-03-13
Reporting File Number021-233180
Mailing Address955 MASSACHUSETTS AVE CAMBRIDGE, MASSACHUSETTS 02139
StateDELAWARE
Contact Phone339-203-1076
Fiscal Year End Date1231
Filings
Title
Date
Description
SC 13D - General statement of acquisition of beneficial ownership
2018-12-06 16:20:05-05:00
SC 13D
D/A [Amend] - Notice of Exempt Offering of Securities
2018-09-21 13:53:12-04:00
D/A [Amend]
D - Notice of Exempt Offering of Securities
2017-11-15 15:20:43-05:00
D
D - Notice of Exempt Offering of Securities
2015-08-28 10:48:55-04:00
D
D - Notice of Exempt Offering of Securities
2015-01-30 14:07:51-05:00
D

© 2019 SEC.report
This site is not affiliated with or endorsed by the SEC.
The SEC operates under the authority of Title 17 of the Code of Federal Regulations.